Breakthrough Coronavirus Drug: Dexamethasone Proves to be the First Life-saving Drug

If the medication had been available at UK hospital from the onset, as many as 5,000 lives might have been saved, in developing nations with heavy Covid-19 cases, that could be a major advantage.

Coronavirus Drug: Dexamethasone
A cheap and common drug will save the lives. Upsplash Images

Dexamethasone, a small-dose steroid drug, has proven to be a significant advance in treating the lethal coronavirus, according to UK researchers. This cheap and common drug could save the lives of Coronavirus patients. The drug is part of the greatest current coronavirus study worldwide. For patients on ventilators, it decreases by a third the chance of death. If the medication had been available at UK hospital from the onset, as many as 5,000 lives might have been saved, in developing nations with heavy Covid-19 cases, that could be a major advantage.

Prime Minister Boris Johnson claimed there was a real reason to rejoice “a remarkable British scientific achievement”, adding: “We have taken steps to ensure we have enough supplies, even in the event of a second peak.”

The British government is stockpiling 200,000 treatment classes and claims the NHS will supply Dexamethasone. Approximately 19 of 20 Coronavirus patients recover without hospital admission. Of the admitted, most recover, but some may require respiratory support or oxygen. 

Dexamethasone also seems to be helpful in these high-risk patients. It cuts fatalities by a fifth for those on oxygen. For certain disorders, including diabetes, allergies, and other skin problems, the medication is often used to minimize inflammatory response. It also seems to support patients to avoid any of the harm that can occur as the human immune system becomes overdriven when it attempts to defend off coronavirus.

Is Dexamethasone Officially The Coronavirus Drug?

Chief investigator Prof Peter Horby said: “This is the only drug so far that has been shown to reduce mortality – and it reduces it significantly. It’s a breakthrough.”

Approximately 2,000 hospital patients obtained Dexamethasone, and over 4,000 patients were assessed in the study, led by an Oxford University team. For patients on ventilators, the chance of mortality decreased from 40% to 28%. Patients using oxygen have a 25% to 20% chance of mortality. The results indicated one-life could be saved for eight ventilator-treated patients and every 20-25 on oxygen.

The first product that has shown to curb Covid-19 fatalities is a familiar, affordable-as-chip drug, rather than anything new and costly. It is something to be appreciated since it ensures people globally will profit instantly. That is why the leading outcomes of this study have been precipitated because internationally, the consequences are too immense. Professor Landray said it should now be offered to hospital patients without hesitation. However, people shouldn’t administer it from home.

“There is a clear, clear benefit. The treatment is up to 10 days of dexamethasone and it costs about £5 per patient. So essentially, it costs £35 to save a life. This is a globally available drug,” he said.


Dexamethasone and Other Trial Drugs Have Limitations

Dexamethasone tends not to benefit patients with mild or moderate virus signs. However, this is the greatest COVID-19 test results to date. In March, the recovery study investigated the hydroxychloroquine malaria medication can raise mortality rates as well as cardiac diseases. The NHS now also offers antiviral drugs, like Remdesivir, which seems to reduce the healing process for patients with coronavirus. Remdesivir, also used for Ebola, is the other primary medicine that has proven beneficial to COVID-19 patients.

The span of Coronavirus effects was also decreased to 15 and 11 days. Yet the data was too inadequate to prove that mortality was reduced. Remdesivir, compared to Dexamethasone, is a novel medication with small availability, and the pricing has not yet been released. Dexamethasone has been approved for various treatments, including rheumatoid arthritis and asthma, since the beginning of the 1960s. The reduction of this risk by a third would affect enormously since a good portion of COVID-19 patients who require ventilating do not usually stay alive. The medication is prescribed orally to people who are moderately sick and in a pill shape.

About Faith Sanyu

Faith SanyuI write about world economies and business, the humorous and sarcastic side of politics and world events, lifestyle, religion/beliefs and culture, health, agriculture, history, people's well-being, entertainment, fashion, and humanitarian works.

Have a tip we should know?

Follow @rushhourdaily: